TAS2R43

gene
On this page

Also known as T2R52

Summary

TAS2R43 (taste 2 receptor member 43, HGNC:18875) is a protein-coding gene on chromosome 12p13.2, encoding Taste receptor type 2 member 43 (P59537). Gustducin-coupled receptor immplicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract.

TAS2R43 belongs to the large TAS2R receptor family. TAS2Rs are expressed on the surface of taste receptor cells and mediate the perception of bitterness through a G protein-coupled second messenger pathway (Conte et al., 2002 [PubMed 12584440]). For further information on TAS2Rs, see MIM 604791.

Source: NCBI Gene 259289 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 5 total
  • Druggable target: yes — 1 molecules with ChEMBL bioactivity
  • MANE Select transcript: NM_176884

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18875
Approved symbolTAS2R43
Nametaste 2 receptor member 43
Location12p13.2
Locus typegene with protein product
StatusApproved
AliasesT2R52
Ensembl geneENSG00000255374
Ensembl biotypeprotein_coding
OMIM612668
Entrez259289

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000531678

RefSeq mRNA: 1 — MANE Select: NM_176884 NM_176884

CCDS: CCDS53749

Canonical transcript exons

ENST00000531678 — 1 exons

ExonStartEnd
ENSE000021568311109128711092313

Expression profiles

Bgee: expression breadth broad, 95 present calls, max score 85.78.

Top tissues by expression

112 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.78gold quality
adrenal tissueUBERON:001830362.47gold quality
hindlimb stylopod muscleUBERON:000425251.85gold quality
tonsilUBERON:000237249.84silver quality
calcaneal tendonUBERON:000370149.66gold quality
sural nerveUBERON:001548849.64silver quality
bone marrow cellCL:000209248.78gold quality
apex of heartUBERON:000209845.75gold quality
cortical plateUBERON:000534345.09silver quality
bone marrowUBERON:000237143.81gold quality
urinary bladderUBERON:000125542.98gold quality
ganglionic eminenceUBERON:000402342.41gold quality
cortex of kidneyUBERON:000122542.39gold quality
ectocervixUBERON:001224941.69gold quality
liverUBERON:000210741.12gold quality
ovaryUBERON:000099240.77gold quality
descending thoracic aortaUBERON:000234540.77gold quality
ventricular zoneUBERON:000305340.66gold quality
mucosa of stomachUBERON:000119940.54silver quality
left ovaryUBERON:000211940.28gold quality
endometriumUBERON:000129540.18silver quality
right ovaryUBERON:000211840.03gold quality
right hemisphere of cerebellumUBERON:001489039.70gold quality
cerebellar cortexUBERON:000212939.47silver quality
cerebellumUBERON:000203739.35silver quality
cerebellar hemisphereUBERON:000224539.28silver quality
rectumUBERON:000105238.48gold quality
myometriumUBERON:000129638.10gold quality
monocyteCL:000057638.08gold quality
uterine cervixUBERON:000000237.54silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.49

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 10)

  • hTAS2R43 and hTAS2R44 function as cognate bitter taste receptors and do not contribute to the sweet taste of saccharin and acesulfame K. (PMID:15537898)
  • hT2R43 gene allele makes people more sensitive to the bitterness of an artificial sweetener, saccharin; in addition, a closely related gene’s (hT2R44’s) allele also makes people more sensitive to the bitterness of saccharin. (PMID:17702579)
  • Our results show that the expression rate of some of the T2R taste receptor genes was increased significantly in patients with phantogeusia. (PMID:22397221)
  • Studies indicate that bitter-tasting compounds can have specific physiological effects in Bitter-tasting compounds can have specific physiological effects in type 2 taste receptors (T2Rs)-expressing cells. (PMID:22964302)
  • The mutational polymorphism TAS2R43 significantly affects susceptibility to BEN points to a potentially broad role for toxin responses in personal health risks. (PMID:23050764)
  • The effect of the TAS2R43 gene on coffee liking is mediated by caffeine and in particular by the H212R variant. (PMID:24647340)
  • Study demonstrates that the response profiles of the cat bitter receptors Tas2r38 and Tas2r43 are distinct from those of their orthologous human receptors (PMID:26037485)
  • those with at least one sensitive TAS2R38 allele (AP or PP genotype) were more likely to report rejecting liquid medications than were those without a taster allele (AA genotype (PMID:26391354)
  • Bitter Sensing TAS2R50 Mediates the trans-Resveratrol-Induced Anti-inflammatory Effect on Interleukin 6 Release in HGF-1 Cells in Culture. (PMID:33461297)
  • Human intestinal bitter taste receptors regulate innate immune responses and metabolic regulators in obesity. (PMID:34784295)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusTas2r136ENSMUSG00000053217
mus_musculusTas2r120ENSMUSG00000059382
rattus_norvegicusTas2r120ENSRNOG00000021445
rattus_norvegicusTas2r136ENSRNOG00000029561

Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)

Protein

Protein identifiers

Taste receptor type 2 member 43P59537 (reviewed: P59537)

Alternative names: Taste receptor type 2 member 52

All UniProt accessions (1): P59537

UniProt curated annotations — full annotation on UniProt →

Function. Gustducin-coupled receptor immplicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract. Signals through PLCB2 and the calcium-regulated cation channel TRPM5. Activated by the sulfonyl amide sweeteners saccharin and acesulfame K. In airway epithelial cells, binding of bitter compounds increases the intracellular calcium ion concentration and stimulates ciliary beat frequency. May act as chemosensory receptors in airway epithelial cells to detect and eliminate potential noxious agents from the airways.

Subcellular location. Membrane. Cell projection. Cilium membrane.

Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells. Expressed in airway epithelia.

Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.

Similarity. Belongs to the G-protein coupled receptor T2R family.

RefSeq proteins (1): NP_795365* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007960TAS2RFamily

Pfam: PF05296

UniProt features (20 total): topological domain 8, transmembrane region 7, glycosylation site 2, sequence conflict 2, chain 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
9OXAELECTRON MICROSCOPY2.9
9OXBELECTRON MICROSCOPY3

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P59537-F186.820.48

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 161, 176

Function

Pathways and Gene Ontology

Reactome pathways

9 pathways

IDPathway
R-HSA-418594G alpha (i) signalling events
R-HSA-420499Class C/3 (Metabotropic glutamate/pheromone receptors)
R-HSA-9717207Sensory perception of sweet, bitter, and umami (glutamate) taste
R-HSA-162582Signal Transduction
R-HSA-372790Signaling by GPCR
R-HSA-388396GPCR downstream signalling
R-HSA-500792GPCR ligand binding
R-HSA-9709957Sensory Perception
R-HSA-9717189Sensory perception of taste

MSigDB gene sets: 28 (showing top): GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOCC_CELL_PROJECTION_MEMBRANE, GOCC_MOTILE_CILIUM, GOCC_PLASMA_MEMBRANE_REGION, GOCC_CILIARY_MEMBRANE, GOCC_CILIUM, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY

GO Biological Process (4): detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580), G protein-coupled receptor signaling pathway (GO:0007186), signal transduction (GO:0007165), sensory perception of taste (GO:0050909)

GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), taste receptor activity (GO:0008527), bitter taste receptor activity (GO:0033038)

GO Cellular Component (6): plasma membrane (GO:0005886), membrane (GO:0016020), motile cilium (GO:0031514), ciliary membrane (GO:0060170), cilium (GO:0005929), cell projection (GO:0042995)

Reactome top-level categories

Rollup of top-6 pathways:

CategoryPathways
Signaling by GPCR2
GPCR downstream signalling1
GPCR ligand binding1
Sensory perception of taste1
Signal Transduction1
Sensory Perception1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
detection of chemical stimulus involved in sensory perception of taste2
transmembrane signaling receptor activity2
cellular anatomical structure2
cilium2
sensory perception of bitter taste1
G protein-coupled receptor activity1
signal transduction1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
sensory perception of chemical stimulus1
G protein-coupled receptor signaling pathway1
detection of chemical stimulus involved in sensory perception of bitter taste1
taste receptor activity1
membrane1
cell periphery1
cell projection membrane1
bounding membrane of organelle1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1

Protein interactions and networks

STRING

372 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TAS2R43GNAT3A8MTJ3882
TAS2R43PLCB2Q00722867
TAS2R43TAS1R3Q7RTX0522
TAS2R43TAS1R2Q8TE23512
TAS2R43TAS1R1Q7RTX1475
TAS2R43OR52K2Q8NGK3448
TAS2R43OR2T33Q8NG76446
TAS2R43OR52B6Q8NGF0445
TAS2R43A0A087WY73A0A087WY73436
TAS2R43PKD2L1Q9P0L9403
TAS2R43OR8U1Q8NH10398
TAS2R43SCNN1DP51172366
TAS2R43VN1R4Q7Z5H5365
TAS2R43ANKRD36CQ5JPF3365
TAS2R43NUTM2FA1L443359

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: P0DSN6, P0DTE0, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T2, Q645T3, Q645T4, Q645T6, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645Z2, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646B4, Q646B9, Q646C0, Q646C1, Q646C2, Q646C3, Q646E0, Q646E1, Q646E2, Q646E3

Diamond homologs: P0DSN6, P0DTE0, P59528, P59530, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T0, Q645T2, Q645T3, Q645T4, Q645T6, Q645T7, Q645U8, Q645V1, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645V8, Q645V9, Q645Z2, Q645Z5, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646A2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

5 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance3
Likely benign0
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

370 predictions. Top by Δscore:

VariantEffectΔscore
12:11091492:CAT:Cacceptor_gain0.7300
12:11091353:C:CCacceptor_gain0.7200
12:11091622:C:CTacceptor_gain0.7100
12:11091605:TCTTC:Tacceptor_gain0.7000
12:11091615:A:Cacceptor_gain0.6900
12:11091619:T:TCacceptor_gain0.6700
12:11091624:C:CTacceptor_gain0.6700
12:11091635:T:TCacceptor_gain0.6700
12:11091856:A:Cdonor_gain0.6600
12:11091860:T:Adonor_gain0.6600
12:11091625:A:Tacceptor_gain0.6500
12:11091494:T:TCacceptor_gain0.6400
12:11091834:CA:Cdonor_gain0.6400
12:11091835:A:ACdonor_gain0.6400
12:11091471:T:TAdonor_gain0.6200
12:11091606:CTT:Cacceptor_gain0.6200
12:11091617:G:Cacceptor_gain0.6200
12:11092285:T:TAdonor_gain0.6100
12:11091640:A:Tacceptor_gain0.6000
12:11091831:CAACA:Cdonor_gain0.6000
12:11091520:A:ACdonor_gain0.5900
12:11091643:A:Cacceptor_gain0.5900
12:11091609:C:CCacceptor_gain0.5800
12:11091631:C:CTacceptor_gain0.5800
12:11091784:A:Cacceptor_gain0.5800
12:11091864:C:CCacceptor_gain0.5800
12:11091642:C:CTacceptor_gain0.5700
12:11091610:T:Cacceptor_gain0.5600
12:11091632:A:Tacceptor_gain0.5500
12:11091859:CTCCT:Cacceptor_gain0.5500

AlphaMissense

2051 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:11091876:A:CF118L0.850
12:11091876:A:TF118L0.850
12:11091878:A:GF118L0.850
12:11091921:G:CS103R0.849
12:11091921:G:TS103R0.849
12:11091923:T:GS103R0.849
12:11092152:G:CF26L0.807
12:11092152:G:TF26L0.807
12:11092154:A:GF26L0.807
12:11092179:A:CF17L0.794
12:11092179:A:TF17L0.794
12:11092181:A:GF17L0.794
12:11091528:G:CF234L0.782
12:11091528:G:TF234L0.782
12:11091530:A:GF234L0.782
12:11091945:G:CS95R0.778
12:11091945:G:TS95R0.778
12:11091947:T:GS95R0.778
12:11091891:G:CF113L0.759
12:11091891:G:TF113L0.759
12:11091893:A:GF113L0.759
12:11092052:A:GW60R0.727
12:11092052:A:TW60R0.727
12:11092197:A:CS11R0.708
12:11092197:A:TS11R0.708
12:11092199:T:GS11R0.708
12:11091941:A:GW97R0.706
12:11091941:A:TW97R0.706
12:11092158:A:CN24K0.702
12:11092158:A:TN24K0.702

dbSNP variants (sampled 300 via entrez): RS1007662416 (12:11094028 T>C), RS1012269965 (12:11091208 ACAGTATAGAAAAAC>A), RS1013805753 (12:11093243 G>A), RS1027600496 (12:11093913 A>C), RS1027736262 (12:11091287 C>T), RS1036946262 (12:11093287 C>A), RS1055252053 (12:11093056 G>A,C), RS111592023 (12:11090830 G>A,C), RS111630914 (12:11092511 T>G), RS111846092 (12:11091361 A>G,T), RS111852557 (12:11090837 A>T), RS111982292 (12:11091833 A>C,G), RS112843826 (12:11092546 A>C), RS112869592 (12:11092322 G>A,C,T), RS112874084 (12:11092516 T>A,C)

Disease associations

OMIM: gene MIM:612668 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST002144_2Bitter taste perception2.000000e-19
GCST005688_8Idiopathic intracranial hypertension6.000000e-07

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4523251 (SINGLE PROTEIN)

Molecules with ChEMBL bioactivity

1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).

MoleculeNamePhasePatents
CHEMBL434ISOPROTERENOL440,234

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Taste 2 receptors

Most potent curated ligand interactions (13 total), top 13:

LigandActionAffinityParameter
aristolochic acidAgonist7.1pEC50
lactucopicrinAgonist6.34pEC50
aloinAgonist5.92pEC50
Cyclolinopeptide 1-Mso,3-Met-CL6Agonist5.53pEC50
bengalensolAgonist5.41pEC50
grosheiminAgonist5.16pEC50
GIV3727Antagonist4.95pIC50
3-methylhexanalAntagonist4.13pIC50
amarogentinAgonist4.12pEC50
citronellalAntagonist4.08pIC50
saccharinAgonist2.77pEC50
acesulfameAgonist2.51pEC50
cyclamateAntagonist2.32pIC50

ChEMBL bioactivities

1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.31EC504.9nMISOPROTERENOL

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
Folic Acidaffects cotreatment, increases expression, decreases expression2
alloindecreases reaction, increases activity1
pentanaldecreases expression1
MT19c compoundincreases expression1
Ethanolaffects cotreatment, increases expression1
Probeneciddecreases reaction, increases activity, decreases activity1
Silicon Dioxidedecreases expression1
Valproic Aciddecreases methylation1
Sodium Selenitedecreases expression1
Copper Sulfateincreases expression1

ChEMBL screening assays

10 unique, capped per target: 10 functional

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4346436FunctionalAntagonist activity at recombinant human TAS2R43 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of aristolochic acid-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists. — J Med Chem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Targeted by drugs: Acesulfame, Saccharin
  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pseudotumor cerebri